254 related articles for article (PubMed ID: 36055392)
1. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
[TBL] [Abstract][Full Text] [Related]
2. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.
de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL
J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054
[TBL] [Abstract][Full Text] [Related]
3. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Influence of Target Acquisition on Survival, Integration, and Phenotypic Maturation of Dopamine Neurons within Stem Cell-Derived Neural Grafts in a Parkinson's Disease Model.
Moriarty N; Kauhausen JA; Pavan C; Hunt CPJ; de Luzy IR; Penna V; Ermine CM; Thompson LH; Parish CL
J Neurosci; 2022 Jun; 42(25):4995-5006. PubMed ID: 35610045
[TBL] [Abstract][Full Text] [Related]
5. Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.
Niclis JC; Gantner CW; Alsanie WF; McDougall SJ; Bye CR; Elefanty AG; Stanley EG; Haynes JM; Pouton CW; Thompson LH; Parish CL
Stem Cells Transl Med; 2017 Mar; 6(3):937-948. PubMed ID: 28297587
[TBL] [Abstract][Full Text] [Related]
6. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.
Lehnen D; Barral S; Cardoso T; Grealish S; Heuer A; Smiyakin A; Kirkeby A; Kollet J; Cremer H; Parmar M; Bosio A; Knöbel S
Stem Cell Reports; 2017 Oct; 9(4):1207-1220. PubMed ID: 28943253
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Matrix Biomimetic Hydrogels, Encapsulated with Stromal Cell-Derived Factor 1, Improve the Composition of Foetal Tissue Grafts in a Rodent Model of Parkinson's Disease.
Penna V; Moriarty N; Wang Y; Law KCL; Gantner CW; Williams RJ; Nisbet DR; Parish CL
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563037
[TBL] [Abstract][Full Text] [Related]
8. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
[No Abstract] [Full Text] [Related]
9. Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.
Xu P; He H; Gao Q; Zhou Y; Wu Z; Zhang X; Sun L; Hu G; Guan Q; You Z; Zhang X; Zheng W; Xiong M; Chen Y
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700056
[TBL] [Abstract][Full Text] [Related]
10. Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells.
Rifes P; Isaksson M; Rusimbi C; Ramón Santonja A; Nelander J; Laurell T; Kirkeby A
Stem Cell Res Ther; 2023 Dec; 14(1):354. PubMed ID: 38072935
[TBL] [Abstract][Full Text] [Related]
11. Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease.
Shrigley S; Nilsson F; Mattsson B; Fiorenzano A; Mudannayake J; Bruzelius A; Ottosson DR; Björklund A; Hoban DB; Parmar M
J Parkinsons Dis; 2021; 11(2):515-528. PubMed ID: 33361611
[TBL] [Abstract][Full Text] [Related]
12. Neurite Outgrowth and Gene Expression Profile Correlate with Efficacy of Human Induced Pluripotent Stem Cell-Derived Dopamine Neuron Grafts.
Hills R; Mossman JA; Bratt-Leal AM; Tran H; Williams RM; Stouffer DG; Sokolova IV; Sanna PP; Loring JF; Lelos MJ
Stem Cells Dev; 2023 Jul; 32(13-14):387-397. PubMed ID: 37166357
[TBL] [Abstract][Full Text] [Related]
13. Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models.
Naderi S; Shiri Z; Zarei-Kheirabadi M; Mollamohammadi S; Hosseini P; Rahimi G; Moradmand A; Samadian A; Shojaei A; Yeganeh M; Mousavi SA; Badri M; Taei A; Hassani SN; Baharvand H
Life Sci; 2023 Sep; 329():121990. PubMed ID: 37524159
[TBL] [Abstract][Full Text] [Related]
14. Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats.
Cardoso T; Adler AF; Mattsson B; Hoban DB; Nolbrant S; Wahlestedt JN; Kirkeby A; Grealish S; Björklund A; Parmar M
J Comp Neurol; 2018 Sep; 526(13):2133-2146. PubMed ID: 30007046
[TBL] [Abstract][Full Text] [Related]
15. Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.
Kirkeby A; Nolbrant S; Tiklova K; Heuer A; Kee N; Cardoso T; Ottosson DR; Lelos MJ; Rifes P; Dunnett SB; Grealish S; Perlmann T; Parmar M
Cell Stem Cell; 2017 Jan; 20(1):135-148. PubMed ID: 28094017
[TBL] [Abstract][Full Text] [Related]
16. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
[TBL] [Abstract][Full Text] [Related]
17. Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing.
Fiorenzano A; Sozzi E; Parmar M; Storm P
Cells; 2021 Jun; 10(6):. PubMed ID: 34206038
[TBL] [Abstract][Full Text] [Related]
18. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
[TBL] [Abstract][Full Text] [Related]
19. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.
Cooper O; Hargus G; Deleidi M; Blak A; Osborn T; Marlow E; Lee K; Levy A; Perez-Torres E; Yow A; Isacson O
Mol Cell Neurosci; 2010 Nov; 45(3):258-66. PubMed ID: 20603216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
